Rockville, United States
Tetracore Inc is a biotechnology research and development organization specializing in the development of advanced kits, assays, and reagents for the detection of infectious diseases, biological warfare threat agents, and biological markers. The company's focus on antibody-based and nucleic acid-based detection technologies has led to the creation of a broad range of highly-specific, rapid test kits and reagents for the detection of BW infectious agents and toxins. Notably, Tetracore has received FDA clearance for the first test kit designed to identify B. anthracis from colonies. Additionally, the company offers real-time, probe hydrolysis Polymerase Chain Reaction (PCR) tests for animal pathogens and is involved in contracts with the US Government for the development of real-time PCR diagnostic tests, nucleic acid extraction procedures, and specialized nucleic acid products.
The founding scientists of Tetracore, Gary Long, Ph. D., Beverly L. Mangold, Ph.D.*, Thomas W. O'Brien, Ph.D., and William M. Nelson, M.D., bring extensive expertise and skills to the organization. They have been leaders in the development of state-of-the-art diagnostic technology for use by the Joint Program Office for Bio-defense (JPO), the Department of Defense (DOD), FBI, and DOE. Their presence at Tetracore enables the company to provide expanded production capability, greater flexibility in technology development, and an innovative entrepreneurial atmosphere.
Founded in 1999, Tetracore operates within the biotechnology and health care industries. The strong scientific team and powerful technology base position the company at the forefront of developing important detection tools for Clinical, Animal Health, and Domestic Preparedness Testing.
